查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1675361

2025 年至 2033 年黏彈性補充劑市場按類型、年齡層、配銷通路、應用、最終用途和地區分類

Viscosupplementation Market by Type, Age Group, Distribution Channel, Application, End Use, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2024IMARC Group全球黏液補充劑市場規模達到 48 億美元。骨質疏鬆症和骨關節炎（OA）盛行率的不斷上升，以及消費者越來越傾向於微創非手術治療，是推動市場發展的一些關鍵因素。

黏彈性補充療法是一種微創醫療程序，其中將包含凝膠狀液體（稱為外源性液壓酸 (HA) 衍生物）的關節內注射直接注射到患者的膝關節中。它充當潤滑劑，使骨骼能夠彼此順利移動，減輕炎症，並充當關節負荷的減震器。黏彈性補充療法可減少運動過程中的摩擦，幫助滑液形成更多的緩衝，消除劇烈疼痛，並增強關節的活動範圍。除此之外，它還能恢復滑液的流變特性，產生機械、鎮痛、抗發炎和軟骨保護作用。因此，黏彈性補充療法廣泛應用於膝關節、髖關節和手部骨關節炎的治療。目前主要有中、低、高分子量。

黏液補充市場趨勢：

骨質疏鬆症和骨關節炎（OA）盛行率的不斷上升是推動市場成長的關鍵因素之一。同時，消費者越來越傾向於微創非手術治療方案，這促進了醫療保健領域廣泛採用黏彈性補充劑來治療皮質類固醇和關節疼痛。這反過來又成為另一個重要的成長誘導因素。這進一步受到消費者對非手術治療的多種益處的認知不斷提高的影響，包括無需住院、費用更少、併發症更少、臨床結果和恢復率更好。此外，政府的優惠措施和各製藥公司為推出新藥和不同給藥途徑而進行的大量投資也支持了市場的成長。此外，提供強化治療以解決關節、韌帶、肌肉、脊椎和神經等身體各部位的手術和非手術問題的門診手術中心 (ACS) 的出現有利於市場的成長。此外，含有液壓酸的開放標籤單次注射劑的推出正在推動市場成長。除此之外，優惠的健康保險報銷政策、易患慢性疾病的老年人口不斷增加、慢性殘疾人數量不斷增加、主要參與者之間的合作與夥伴關係以及醫學科學領域的持續研發活動都對市場成長產生了積極影響。

本報告回答的關鍵問題：

  • 到目前為止，全球黏液補充市場表現如何？
  • 全球黏液補充市場有哪些促進因素、限制因素和機會？
  • 主要的區域市場有哪些？
  • 哪些國家擁有最具吸引力的黏液補充市場？
  • 根據類型，市場區隔是怎樣的？
  • 根據年齡段，市場如何分佈？
  • 根據配銷通路，市場如何分類？
  • 根據應用，市場區隔是怎樣的？
  • 根據最終用途，市場如何分類？
  • 全球黏液補充市場的競爭結構是怎麼樣的？
  • 全球黏液補充市場的主要參與者/公司有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球黏彈性補充市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第6章：市場細分：依類型

  • 單次注射
  • 三次注射
  • 五次注射

第7章：市場區隔：依年齡段

  • 成年人
  • 老年病學

第 8 章：市場區隔：按配銷通路

  • 醫院藥房
  • 零售藥局
  • 網路藥局

第 9 章：市場區隔：按應用

  • 膝關節骨關節炎
  • 髖關節骨關節炎
  • 手部骨關節炎
  • 其他

第 10 章：市場區隔：最終用途別

  • 醫院
  • 骨科診所
  • 其他

第 11 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 12 章：促進因素、限制因素與機遇

  • 概述
  • 驅動程式
  • 限制
  • 機會

第 13 章：價值鏈分析

第 14 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 15 章：價格分析

第 16 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Anika Therapeutics Inc.
    • Aptissen SA
    • Bioventus LLC
    • Ferring Pharmaceuticals
    • Fidia Farmaceutici SpA
    • Johnson & Johnson
    • LG Chem Ltd.
    • OrthogenRx Inc. (Avanos Medical Inc.)
    • Sanofi SA
    • Seikagaku Corporation
    • Virchow Biotech Private Limited
    • Zimmer Biomet
    • Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited)
Product Code: SR112025A6931

The global viscosupplementation market size reached USD 4.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.1 Billion by 2033, exhibiting a growth rate (CAGR) of 7.05% during 2025-2033. The increasing prevalence of osteoporosis and osteoarthritis (OA) and the shifting consumer inclination toward minimally invasive non-surgical treatments represent some of the key factors driving the market.

Viscosupplementation represents a minimally invasive medical procedure wherein intraarticular injection comprising gel-like fluid known as exogenous hydraulic acid (HA) derivatives are directly administered into the knee joints of the patient. It acts as a lubricant, which enables bones to move smoothly over each other, lowers inflammation, and performs as a shock absorber for joint loads. Viscosupplementation reduces the friction during the movements, assists the synovial fluids in creating more cushion, eliminates severe pain, and enhances the range of movements or motions of the joint. Apart from this, it restores the rheological properties of the synovial fluids, which produce mechanical, analgesic, anti-inflammatory, and chondroprotective effects. As a result, viscosupplementation is extensively utilized in the treatment of knee, hip, and hand osteoarthritis. Currently, it is mainly available in intermediate, low, and high molecular weights.

Viscosupplementation Market Trends:

The increasing prevalence of osteoporosis and osteoarthritis (OA) represents one of the key factors driving the market growth. In line with this, the shifting consumer inclination toward the minimally invasive non-surgical treatment options has facilitated the widespread adoption of viscosupplementation in the healthcare sector for corticosteroids and joint pain management. This, in turn, is acting as another major growth-inducing factor. This is further influenced by the growing consumer awareness regarding the multiple benefits of non-surgical treatments, including no hospitalization, fewer expenses, minimal complications, and better clinical outcomes and recovery rates. Additionally, the favorable government initiatives and significant investments by various pharmaceutical companies to launch novel drugs and different routes of administrations is supporting the market growth. Moreover, the emergence of ambulatory surgical centers (ACS) that offer intensive treatment to resolve surgical and non-surgical problems in various body parts, such as joints, ligaments, muscle, spine, and nerves, is favoring the market growth. Furthermore, the introduction of open-label single-injections with hydraulic acid is propelling the market growth. Apart from this, favorable health insurance reimbursement policies, the rising geriatric population, which is susceptible to chronic ailments, increasing number of individuals with chronic disability, collaborations and partnership among the key players, and continuous research and development (R&D) activities in the field of medical sciences are positively impacting the market growth.

Key Market Segmentation:

Type Insights:

  • Single Injection
  • Three Injection
  • Five Injection
  • The report has also provided a detailed breakup and analysis of viscosupplementation market based on the type. This includes single, three and five injection. According to the report, single injection represented the largest segment.

Age Group Insights:

  • Adults
  • Geriatrics

Distribution Channel Insights:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • The report has also provided a detailed breakup and analysis of viscosupplementation market based on the distribution channel. This includes hospital, retail and online pharmacies. According to the report, hospital pharmacies represented the largest segment.

Application Insights:

  • Knee Osteoarthritis
  • Hip Osteoarthritis
  • Hand Osteoarthritis
  • Others

End Use Insights:

  • Hospitals
  • Orthopedic Clinics
  • Others
  • The report has also provided a detailed breakup and analysis of viscosupplementation market based on the end use. This includes hospitals, orthopedic clinics, and others. According to the report, orthopedic clinics represented the largest segment.

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, the North America was the largest market for viscosupplementation. Some of the factors driving the North America viscosupplementation market included the rising geriatric population and the affordable health insurance reimbursement policies.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global viscosupplementation market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Anika Therapeutics Inc., Aptissen S.A., Bioventus LLC, Ferring Pharmaceuticals, Fidia Farmaceutici S.p.A., Johnson & Johnson, LG Chem Ltd., OrthogenRx Inc. (Avanos Medical Inc.), Sanofi S.A., Seikagaku Corporation, Virchow Biotech Private Limited, Zimmer Biomet, Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited), etc.

Key Questions Answered in This Report:

  • How has the global viscosupplementation market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global viscosupplementation market?
  • What are the key regional markets?
  • Which countries represent the most attractive viscosupplementation markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the age group?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end use?
  • What is the competitive structure of the global viscosupplementation market?
  • Who are the key players/companies in the global viscosupplementation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Viscosupplementation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Single Injection
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Three Injection
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Five Injection
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Age Group

  • 7.1 Adults
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Geriatrics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Knee Osteoarthritis
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hip Osteoarthritis
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Hand Osteoarthritis
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by End Use

  • 10.1 Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Orthopedic Clinics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 Drivers, Restraints, and Opportunities

  • 12.1 Overview
  • 12.2 Drivers
  • 12.3 Restraints
  • 12.4 Opportunities

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Anika Therapeutics Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Aptissen S.A.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Bioventus LLC
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
    • 16.3.4 Ferring Pharmaceuticals
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Fidia Farmaceutici S.p.A.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Johnson & Johnson
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 LG Chem Ltd.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 OrthogenRx Inc. (Avanos Medical Inc.)
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Sanofi S.A.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Seikagaku Corporation
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
    • 16.3.11 Virchow Biotech Private Limited
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
    • 16.3.12 Zimmer Biomet
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited)
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Viscosupplementation Market: Major Drivers and Challenges
  • Figure 2: Global: Viscosupplementation Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Viscosupplementation Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Viscosupplementation Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Viscosupplementation Market: Breakup by Age Group (in %), 2024
  • Figure 6: Global: Viscosupplementation Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Viscosupplementation Market: Breakup by Application (in %), 2024
  • Figure 8: Global: Viscosupplementation Market: Breakup by End Use (in %), 2024
  • Figure 9: Global: Viscosupplementation Market: Breakup by Region (in %), 2024
  • Figure 10: Global: Viscosupplementation (Single Injection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Viscosupplementation (Single Injection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Viscosupplementation (Three Injection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Viscosupplementation (Three Injection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Viscosupplementation (Five Injection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Viscosupplementation (Five Injection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Viscosupplementation (Adults) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Viscosupplementation (Adults) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Viscosupplementation (Geriatrics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Viscosupplementation (Geriatrics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Viscosupplementation (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Viscosupplementation (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Viscosupplementation (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Viscosupplementation (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Viscosupplementation (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Viscosupplementation (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Viscosupplementation (Knee Osteoarthritis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Viscosupplementation (Knee Osteoarthritis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Viscosupplementation (Hip Osteoarthritis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Viscosupplementation (Hip Osteoarthritis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Viscosupplementation (Hand Osteoarthritis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Viscosupplementation (Hand Osteoarthritis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Viscosupplementation (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Viscosupplementation (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Viscosupplementation (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Viscosupplementation (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Viscosupplementation (Orthopedic Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Viscosupplementation (Orthopedic Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Viscosupplementation (Other End Uses) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Viscosupplementation (Other End Uses) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: North America: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: North America: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: United States: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: United States: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Canada: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Canada: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Asia-Pacific: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Asia-Pacific: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: China: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: China: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Japan: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Japan: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: India: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: India: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: South Korea: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: South Korea: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Australia: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Australia: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Indonesia: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Indonesia: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Europe: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Europe: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Germany: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Germany: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: France: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: France: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: United Kingdom: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: United Kingdom: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Italy: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Italy: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Spain: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Spain: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Russia: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Russia: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Latin America: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Latin America: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Brazil: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Brazil: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Mexico: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Mexico: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Others: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Others: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Middle East and Africa: Viscosupplementation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Middle East and Africa: Viscosupplementation Market: Breakup by Country (in %), 2024
  • Figure 88: Middle East and Africa: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Global: Viscosupplementation Industry: Drivers, Restraints, and Opportunities
  • Figure 90: Global: Viscosupplementation Industry: Value Chain Analysis
  • Figure 91: Global: Viscosupplementation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Viscosupplementation Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Viscosupplementation Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Viscosupplementation Market Forecast: Breakup by Age Group (in Million USD), 2025-2033
  • Table 4: Global: Viscosupplementation Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Viscosupplementation Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 6: Global: Viscosupplementation Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 7: Global: Viscosupplementation Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Viscosupplementation Market: Competitive Structure
  • Table 9: Global: Viscosupplementation Market: Key Players